PLRX FY 2022 Earnings — Pliant Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

PLRXPliant Therapeutics, Inc.

$85M

FY 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$10M+27.9% YoY

Gross Profit

$10M100.0% margin

Operating Income

-$127M-1313.4% margin

Net Income

-$123M-1273.3% margin

EPS (Diluted)

$-2.94

Cash Flow

Operating Cash Flow

-$95M

Free Cash Flow

-$96M

Stock-Based Comp.

$23M

Balance Sheet

Total Assets

$351M

Total Liabilities

$37M

Stockholders' Equity

$313M

Cash & Equivalents

$34M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$10M	$8M	+27.9%
Gross Profit	$10M	$8M	+27.9%
Operating Income	-$127M	-$98M	-30.4%
Net Income	-$123M	-$97M	-26.8%